Rivaroxaban Versus Warfarin for Management of Obese African Americans With Non-Valvular Atrial Fibrillation or Venous Thromboembolism: A Retrospective Cohort Analysis

by Olivia S. Costa PharmD, Jan Beyer-Westendorf MD, Veronica Ashton MPH, Dejan Milentijevic PhD, MBA, Kenneth Todd Moore MS, Thomas J. Bunz PharmD, PhD, Craig I. Coleman PharmD
Published 2020-10-01